Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. Lal PathLabsNSE:LALPATHLAB -0.21%93 Days Inventory is 14.96 as of Jun. 2026, which is 50% below its 10-year median of 30.11. GuruFocus rates NSE:LALPATHLAB with a GF Score™ of 93/100 and a GF Value™ of ₹1,735.83 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Dr. Lal PathLabs ranks better than 87.57% on this metric.
The historical rank and industry rank for Dr. Lal PathLabs's Days Inventory or its related term are showing as below:
NSE:LALPATHLAB'
s Days Inventory Range Over the Past 10 Years
Min: 16.98 Med: 30.11 Max: 38.87
Current: 18.1
During the past 13 years, Dr. Lal PathLabs's highest Days Inventory was 38.87. The lowest was 16.98. And the median was 30.11.
NSE:LALPATHLAB's Days Inventory is ranked better than 87.57% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.64
vs NSE:LALPATHLAB: 18.10
Dr. Lal PathLabs's Days Inventory
increased
from Jun. 2025 (14.67) to Jun. 2026 (14.96).
It might indicate that Dr. Lal PathLabs's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Dr. Lal PathLabs's Inventory Turnover for the
three
months ended in Jun. 2026 was 6.10.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dr. Lal PathLabs's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.05.
Dr. Lal PathLabs (NSE:LALPATHLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Dr. Lal PathLabs's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dr. Lal PathLabs's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Dr. Lal PathLabs Days Inventory Related Terms
Dr. Lal PathLabs Days Inventory Historical Data
* Premium members only.
The historical data trend for Dr. Lal PathLabs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LALPATHLAB vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Lal PathLabs Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Dr. Lal PathLabs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Lal PathLabs (NSE:LALPATHLAB) has a Days Inventory of 14.96 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dr. Lal PathLabs and its competitors. This is 50% below median its historical median of 30.11. Over the past decade, Dr. Lal PathLabs' Days Inventory has ranged from 16.98 to 38.87. According to the industry distribution chart, Dr. Lal PathLabs ranks #22 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 12.4%.
Is Dr. Lal PathLabs' Days Inventory too high?
Dr. Lal PathLabs' current Days Inventory of 14.96 is 50% below median its 10-year median of 30.11. Over the past 10 years, this metric has ranged from a low of 16.98 to a high of 38.87. The Medical Diagnostics & Research industry median Days Inventory is 67.64. Dr. Lal PathLabs' value of 14.96 is 77.9% below this industry median. Based on the distribution chart, Dr. Lal PathLabs ranks #22 out of 177 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Dr. Lal PathLabs has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Dr. Lal PathLabs ranks #22 out of 177 companies for Days Inventory. This places Dr. Lal PathLabs in the top 12% of its industry — outperforming the majority of peers. The industry median Days Inventory is 67.64. Dr. Lal PathLabs' value of 14.96 is 77.9% below this benchmark. Historically, Dr. Lal PathLabs' own Days Inventory has ranged from 16.98 to 38.87 over the past decade. While the company's 10-year median is 30.11 vs. the industry median of 67.64, Dr. Lal PathLabs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.64, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Lal PathLabs's current Days Inventory of 14.96 is 77.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dr. Lal PathLabs and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Lal PathLabs's current Days Inventory is 14.96, which is 50% below median its own 10-year median of 30.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (NSE:LALPATHLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,735.83, compared to a current price of ₹1,949.90 — trading 12.3% above its estimated fair value. The current Days Inventory is 14.96, which is 50% below median its 10-year median of 30.11 and 77.9% below the Medical Diagnostics & Research industry median of 67.64. Dr. Lal PathLabs' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Dr. Lal PathLabs (NSE:LALPATHLAB), the current Days Inventory is 14.96 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued.
The current stock price of ₹1,949.90 is trading 12.3% above its estimated GF Value™ of ₹1,735.83.
GuruFocus considers Dr. Lal PathLabs to be Modestly Overvalued.
Key valuation signals for NSE:LALPATHLAB:
Days Inventory: 14.96 (50% below median its 10-year median of 30.11)
GF Value™: ₹1,735.83 vs. price of ₹1,949.90 (12.3% above fair value)
Industry Position: 77.9% below the Medical Diagnostics & Research median (#22 of 177)
No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
93GF Score
Get the complete analysis for NSE:LALPATHLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LALPATHLAB has been successfully added to your 
